Minireviews
Copyright ©The Author(s) 2021.
World J Virol. Mar 25, 2021; 10(2): 62-68
Published online Mar 25, 2021. doi: 10.5501/wjv.v10.i2.62
Table 3 Comparison of the novel coronavirus disease 2019 vaccines in clinical trials
Vaccine
Clinical trials
Pfizer vaccine (Name: BNT 162b2)
Type: mRNA
Age: ≥ 16 years old
Dose: 30 μg (0.3 mL) twice (21 d interval)
Efficiency (95%CI): 95.0% (90.3-97.6)
Moderna vaccine (Name: mRNA-1273)
Type: mRNA
Age: ≥ 18 years old
Dose: 100 μg (0.5 mL) twice (28 d interval)
Efficiency (95%CI): 94.5% (86.5-97.8)
AstraZeneca vaccine (Name: ChAdOx1)
Type: Virus vector
Age: ≥ 18 years old
Dose: Low doss: 2.2 × 1010 virus particle andStandard dose: 5 × 1010 virus particle, twice (28 d interval)
Efficiency (95%CI): 90.0% (67.4-97.0)